Publications dans lesquelles il/elle collabore avec DAVID NAVARRO ORTEGA (52)

2024

  1. Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis

    The Lancet Microbe, Vol. 5, Núm. 1, pp. e43-e51

2022

  1. Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 4, pp. 657-662

  2. Population-based sequencing of Mycobacterium tuberculosis reveals how current population dynamics are shaped by past epidemics

    eLife, Vol. 11

  3. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination

    Journal of Medical Virology, Vol. 94, Núm. 8, pp. 3776-3782

2021

  1. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  2. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2019

  1. Adoption of new technologies in laboratory workflow practices for positive blood culture bottles: a cross-sectional survey among hospitals in the Autonomous Community of Valencia, Spain

    European Journal of Clinical Microbiology and Infectious Diseases

  2. Candidemia in solid organ transplant recipients in Spain: Epidemiological trends and determinants of outcome

    Transplant Infectious Disease, Vol. 21, Núm. 6

  3. Evaluation of the DNA microarray “AMR Direct Flow Chip Kit” for detection of antimicrobial resistance genes from Gram-positive and Gram-negative bacterial isolated colonies

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 7, pp. 454-457

  4. Missing cases of herpes simplex virus (HSV) infection of the central nervous system when the Reller criteria are applied for HSV PCR testing: A multicenter study

    Journal of Clinical Microbiology, Vol. 57, Núm. 2

2018

  1. A survey on practices for active surveillance of carriage of multidrug-resistant bacteria in hospitals in the Autonomous Community of Valencia, Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 37, Núm. 11, pp. 2069-2074

2017

  1. Epidemiology and prognosis of candidaemia in elderly patients

    Mycoses, Vol. 60, Núm. 12, pp. 808-817

  2. Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia

    Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8

  3. Identification of a large, fast-expanding HIV-1 subtype B transmission cluster among MSM in Valencia, Spain

    PLoS ONE, Vol. 12, Núm. 2

  4. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance

    Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11

  5. The molecular epidemiology of HIV-1 in the Comunidad Valenciana (Spain): Analysis of transmission clusters

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort

    Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8

  2. Would kinetic analyses of plasma cytomegalovirus DNA load help to reach consensus criteria for triggering the initiation of preemptive antiviral therapy in transplant recipients?

    Clinical Infectious Diseases

2015

  1. A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains

    Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9

  2. Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance

    Journal of Infection, Vol. 71, Núm. 3, pp. 385-394